101 related articles for article (PubMed ID: 12051662)
1. Inhibition of cathepsin G by 2-amino-3,1-benzoxazin-4-ones: kinetic investigations and docking studies.
Gütschow M; Kuerschner L; Pietsch M; Ambrozak A; Neumann U; Günther R; Hofmann HJ
Arch Biochem Biophys; 2002 Jun; 402(2):180-91. PubMed ID: 12051662
[TBL] [Abstract][Full Text] [Related]
2. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
4. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
Duranton J; Adam C; Bieth JG
Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
[TBL] [Abstract][Full Text] [Related]
5. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cathepsin G by 4H-3,1-benzoxazin-4-ones.
Gütschow M; Neumann U
Bioorg Med Chem; 1997 Oct; 5(10):1935-42. PubMed ID: 9370038
[TBL] [Abstract][Full Text] [Related]
7. New potent cathepsin G phosphonate inhibitors.
Sieńczyk M; Lesner A; Wysocka M; Legowska A; Pietrusewicz E; Rolka K; Oleksyszyn J
Bioorg Med Chem; 2008 Oct; 16(19):8863-7. PubMed ID: 18805698
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
9. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
[TBL] [Abstract][Full Text] [Related]
10. Peptide ketobenzoxazole inhibitors bound to cathepsin K.
McGrath ME; Sprengeler PA; Hill CM; Martichonok V; Cheung H; Somoza JR; Palmer JT; Janc JW
Biochemistry; 2003 Dec; 42(51):15018-28. PubMed ID: 14690410
[TBL] [Abstract][Full Text] [Related]
11. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G].
Gladysheva IP; Larionova NI; Gladyshev DP; Tikhonova TV; Kazanskaia NF
Biokhimiia; 1994 Apr; 59(4):513-8. PubMed ID: 8018773
[TBL] [Abstract][Full Text] [Related]
12. Novel azapeptide inhibitors of hepatitis C virus serine protease.
Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
[TBL] [Abstract][Full Text] [Related]
13. Defining the substrate specificity of mouse cathepsin P.
Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
[TBL] [Abstract][Full Text] [Related]
14. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
Maryanoff BE
J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
[No Abstract] [Full Text] [Related]
16. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
[TBL] [Abstract][Full Text] [Related]
17. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
Löser R; Schilling K; Dimmig E; Gütschow M
J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
[TBL] [Abstract][Full Text] [Related]
18. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies.
Weir MP; Bethell SS; Cleasby A; Campbell CJ; Dennis RJ; Dix CJ; Finch H; Jhoti H; Mooney CJ; Patel S; Tang CM; Ward M; Wonacott AJ; Wharton CW
Biochemistry; 1998 May; 37(19):6645-57. PubMed ID: 9578548
[TBL] [Abstract][Full Text] [Related]
19. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.
Attucci S; Korkmaz B; Juliano L; Hazouard E; Girardin C; Brillard-Bourdet M; Réhault S; Anthonioz P; Gauthier F
Biochem J; 2002 Sep; 366(Pt 3):965-70. PubMed ID: 12088507
[TBL] [Abstract][Full Text] [Related]
20. Specificity determinants of human cathepsin s revealed by crystal structures of complexes.
Pauly TA; Sulea T; Ammirati M; Sivaraman J; Danley DE; Griffor MC; Kamath AV; Wang IK; Laird ER; Seddon AP; Ménard R; Cygler M; Rath VL
Biochemistry; 2003 Mar; 42(11):3203-13. PubMed ID: 12641451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]